These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2552211)
1. [Carbohydrate antigens in pleural effusion from patients with lung cancer]. Hiratani K; Sakito O; Mukae H; Morikawa N; Kadota J; Fukushima K; Komori K; Hirota M; Hara K Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):673-8. PubMed ID: 2552211 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions. Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750 [TBL] [Abstract][Full Text] [Related]
3. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Kohno N; Akiyama M; Kyoizumi S; Hakoda M; Kobuke K; Yamakido M Jpn J Clin Oncol; 1988 Sep; 18(3):203-16. PubMed ID: 3411786 [TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer]. Fujii M; Kiura K; Kamei H; Segawa Y Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):519-23. PubMed ID: 2852270 [No Abstract] [Full Text] [Related]
5. [A case of lung cancer producing CA19-9 and amylase]. Takano Y; Iwakiri T; Ichiyasu Y Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):267-70. PubMed ID: 7685838 [TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of various tumor markers in pleural effusion and in the serum]. Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951 [TBL] [Abstract][Full Text] [Related]
7. [Pathological study of carbohydrate antigens in human lung cancer with monoclonal antibodies]. Kimura S; Saitou D; Kimura K; Yakata M; Hakomori S Rinsho Byori; 1991 Jul; 39(7):765-72. PubMed ID: 1656116 [TBL] [Abstract][Full Text] [Related]
8. [Tumor marker in lung cancer]. Shijubo N; Abe S Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790 [No Abstract] [Full Text] [Related]
9. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions. Li CS; Cheng BC; Ge W; Gao JF Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer. Hanski C; Hanski ML; Zimmer T; Ogorek D; Devine P; Riecken EO Cancer Res; 1995 Feb; 55(4):928-33. PubMed ID: 7850810 [TBL] [Abstract][Full Text] [Related]
11. [Measurement of CA19-9 in bronchial lavage fluid from patients with lung cancer]. Asada K; Ogushi F; Tani K; Kawaji K; Nakahira S; Yasuoka S; Ogura T Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1682-6. PubMed ID: 1447844 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis. Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855 [TBL] [Abstract][Full Text] [Related]
13. [The diagnostic values of CA242 combining other tumor markers for lung cancer]. Zhang S; Ma Y; Yang X Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851 [TBL] [Abstract][Full Text] [Related]
14. [Availability of the carbohydrate antigen (sialylated Lewis) as a tumor marker in pleural effusion]. Hiratani K; Hirota M; Fukushima K; Tomonaga A; Saito A; Hara K; Fujiwara K Gan To Kagaku Ryoho; 1986 Aug; 13(8):2678-80. PubMed ID: 3017233 [No Abstract] [Full Text] [Related]
15. [Clinical evaluation and tissue distribution of CA125 in patients with pleural effusion]. Tomita Y Igaku Kenkyu; 1989 Nov; 59(3):90-6. PubMed ID: 2639592 [TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Kannagi R; Fukushi Y; Tachikawa T; Noda A; Shin S; Shigeta K; Hiraiwa N; Fukuda Y; Inamoto T; Hakomori S Cancer Res; 1986 May; 46(5):2619-26. PubMed ID: 3008996 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Miédougé M; Rouzaud P; Salama G; Pujazon MC; Vincent C; Mauduyt MA; Reyre J; Carles P; Serre G Br J Cancer; 1999 Nov; 81(6):1059-65. PubMed ID: 10576665 [TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type]. Klech H; Rona G; Hutter C; Bayer PM; Kummer F Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811 [TBL] [Abstract][Full Text] [Related]
19. Lung carcinoma-reactive antibodies isolated from tumor tissues and pleural effusions of lung cancer patients. Paluch E; Ioachim HL J Natl Cancer Inst; 1978 Aug; 61(2):319-25. PubMed ID: 79656 [TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients. Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]